ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

EYPT vs BNGO // OPERATING MARGIN

EyePoint Inc. (NASDAQ) VS. Bionano Genomics Inc. (NASDAQ) • 15-METRIC TALLY: EYPT 1 — BNGO 3
■ METRIC PARITY
operating-margins
-60.00%
operating-margins
-60.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EYPT VS. BNGO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC EYPT BNGO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 46.30% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin ACTIVE -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -27.50% -7.40% -20.10 BNGO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 4/9 -3.00 BNGO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 15.7 34.4 -18.78 BNGO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $32.8M $16.8M $16.0M EYPT /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR EYPT REV BNGO REV EYPT GROSS % BNGO GROSS % EYPT FCF BNGO FCF
FY 2025 $31.4M $28.5M — 46.3% -$243.4M -$16.3M
FY 2024 $43.3M $30.8M — 1.2% -$130.3M -$68.9M
FY 2023 $46.0M $36.1M — — $1.9M -$125.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EYPT // BETA —
BNGO // BETA —